These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

587 related articles for article (PubMed ID: 12509916)

  • 41. Loss of heterozygosity at 3p14.2 in clear cell renal cell carcinoma is an early event and is highly localized to the FHIT gene locus.
    Velickovic M; Delahunt B; Grebe SK
    Cancer Res; 1999 Mar; 59(6):1323-6. PubMed ID: 10096566
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The putative tumor suppressor gene FHIT at 3p14.2 is rarely affected by loss of heterozygosity in primary human brain tumors.
    Frank S; Müller J; Plaschke J; Hahn M; Hampl J; Hampl M; Pistorius S; Schackert G; Schackert HK
    Cancer Res; 1997 Jul; 57(13):2638-41. PubMed ID: 9205070
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Loss of heterozygosity of the VHL gene identifies malignancy and predicts death in follicular thyroid tumors.
    Hunt JL; Yim JH; Tometsko M; Finkelstein SD; Swalsky P; Carty SE
    Surgery; 2003 Dec; 134(6):1043-7; discussion 1047-8. PubMed ID: 14668739
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chromosome 3 allelic losses and microsatellite alterations in transitional cell carcinoma of the urinary bladder.
    Li M; Zhang ZF; Reuter VE; Cordon-Cardo C
    Am J Pathol; 1996 Jul; 149(1):229-35. PubMed ID: 8686747
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Loss of heterozygosity on chromosome 3p in breast cancer and precancerous lesion].
    Tang XL; Yao GY; Chen LR; Yang ZR; Li SL
    Zhonghua Wai Ke Za Zhi; 2006 Oct; 44(19):1314-7. PubMed ID: 17217815
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Detailed mapping and clinical significance of loss of heterozygosity on 9p13-23 in laryngeal squamous cell carcinoma by microsatellite analysis].
    Xu XF; Tang PZ; Cheng SJ
    Ai Zheng; 2003 May; 22(5):452-7. PubMed ID: 12753701
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hypermethylation and loss of heterozygosity of tumor suppressor genes on chromosome 3p in cervical cancer.
    Choi CH; Lee KM; Choi JJ; Kim TJ; Kim WY; Lee JW; Lee SJ; Lee JH; Bae DS; Kim BG
    Cancer Lett; 2007 Sep; 255(1):26-33. PubMed ID: 17467893
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Loss of heterozygosity on chromosomes 3, 9, 13, and 17, including the retinoblastoma locus, in uveal melanoma.
    Scholes AG; Liloglou T; Maloney P; Hagan S; Nunn J; Hiscott P; Damato BE; Grierson I; Field JK
    Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2472-7. PubMed ID: 11581185
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interstitial deletions including chromosome 3 common eliminated region 1 (C3CER1) prevail in human solid tumors from 10 different tissues.
    Petursdottir TE; Thorsteinsdottir U; Jonasson JG; Moller PH; Huiping C; Bjornsson J; Egilsson V; Imreh S; Ingvarsson S
    Genes Chromosomes Cancer; 2004 Nov; 41(3):232-42. PubMed ID: 15334546
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Hypermethylation of fragile histidine triad gene and 3p14 allelic deletion in ovarian carcinomas].
    Hong FZ; Wang B; Li HM; Liew CT
    Zhonghua Bing Li Xue Za Zhi; 2005 May; 34(5):257-61. PubMed ID: 16181544
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Analysis of FHIT allelic imbalance/loss of heterozygosity and FHIT expression in cutaneous squamous cell carcinomas.
    Gray SE; Kay E; Leader M; Mabruk M
    J Cutan Pathol; 2008 Sep; 35(9):816-25. PubMed ID: 18494825
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Location of candidate tumour suppressor gene loci at chromosomes 3p, 8p and 9p for oral squamous cell carcinomas.
    Partridge M; Emilion G; Pateromichelakis S; Phillips E; Langdon J
    Int J Cancer; 1999 Oct; 83(3):318-25. PubMed ID: 10495423
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Definition of three minimal deleted regions by comprehensive allelotyping and mutational screening of FHIT,p16(INK4A), and p19(ARF) genes in nasopharyngeal carcinoma.
    Ko JY; Lee TC; Hsiao CF; Lin GL; Yen SH; Chen KY; Hsiung CA; Chen PJ; Hsu MM; Jou YS
    Cancer; 2002 Apr; 94(7):1987-96. PubMed ID: 11932901
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High frequency loss of heterozygosity in von Hippel-Lindau (VHL)-associated and sporadic pancreatic islet cell tumors: evidence for a stepwise mechanism for malignant conversion in VHL tumorigenesis.
    Lott ST; Chandler DS; Curley SA; Foster CJ; El-Naggar A; Frazier M; Strong LC; Lovell M; Killary AM
    Cancer Res; 2002 Apr; 62(7):1952-5. PubMed ID: 11929809
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunohistochemical and DNA sequencing analysis on human mismatch repair gene MLH1 in cervical squamous cell carcinoma with LOH of this gene.
    Hu X; Guo Z; Pang T; Li Q; Afink G; Pontén J
    Anticancer Res; 2000; 20(1A):171-5. PubMed ID: 10769651
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunohistochemical analysis of expression and allelotype of mismatch repair genes (hMLH1 and hMSH2) in bladder cancer.
    Kassem HS; Varley JM; Hamam SM; Margison GP
    Br J Cancer; 2001 Feb; 84(3):321-8. PubMed ID: 11161395
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genomic alterations and instabilities in renal cell carcinomas and their relationship to tumor pathology.
    Thrash-Bingham CA; Salazar H; Freed JJ; Greenberg RE; Tartof KD
    Cancer Res; 1995 Dec; 55(24):6189-95. PubMed ID: 8521412
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vascular endothelial growth factor overexpression is correlated with von Hippel-Lindau tumor suppressor gene inactivation in patients with sporadic renal cell carcinoma.
    Igarashi H; Esumi M; Ishida H; Okada K
    Cancer; 2002 Jul; 95(1):47-53. PubMed ID: 12115316
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Allelic deletion analysis of the FHIT gene predicts poor survival in non-small cell lung cancer.
    Burke L; Khan MA; Freedman AN; Gemma A; Rusin M; Guinee DG; Bennett WP; Caporaso NE; Fleming MV; Travis WD; Colby TV; Trastek V; Pairolero PC; Tazelaar HD; Midthun DE; Liotta LA; Harris CC
    Cancer Res; 1998 Jun; 58(12):2533-6. PubMed ID: 9635574
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mutational analysis of the von hippel lindau gene in clear cell renal carcinomas from tuberous sclerosis complex patients.
    Duffy K; Al-Saleem T; Karbowniczek M; Ewalt D; Prowse AH; Henske EP
    Mod Pathol; 2002 Mar; 15(3):205-10. PubMed ID: 11904337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.